Dose-response studies on the carcinogenicity of potassium bromate in F344 rats after long-term oral administration. 1986

Y Kurokawa, and S Aoki, and Y Matsushima, and N Takamura, and T Imazawa, and Y Hayashi

Dose-response studies on the carcinogenicity of potassium bromate (KBrO3), a food additive, were undertaken to examine its effects at low doses. A total of 148 6-week-old male inbred F344 rats were divided into 7 groups. They were given KBrO3 orally in their drinking water at doses of 500, 250, 125, 60, 30, 15, and 0 ppm for 104 weeks, at the end of which time all the surviving animals were autopsied and then examined histopathologically. Shortening of the survival times and marked inhibition of body weight increase were observed in a group given 500 ppm KBrO3. The combined incidences of renal adenocarcinomas and adenomas were significantly increased in rats treated with KBrO3 at doses of 500, 250, and 125 ppm in a dose-related manner. The dose-response curve showed a sigmoid appearance. The value for the virtually safe dose (VSD), calculated by the probit model, was 0.950 ppm KBrO3 at a risk level of 10(-6). However, significant increases in the occurrence of dysplastic foci of the kidney were found in groups at doses higher than 30 ppm KBrO3. The VSD value for the dysplastic foci estimated by the gamma-multi-hit model was 0.148 X 10(-3) ppm KBrO3 at a risk level of 10(-6). In a group tested with 500 ppm KBrO3, the combined incidences for follicular adenocarcinomas and adenomas of the thyroid and for mesotheliomas of the peritoneum were shown to be significantly increased.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008297 Male Males
D008654 Mesothelioma A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed) Mesotheliomas
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010534 Peritoneal Neoplasms Tumors or cancer of the PERITONEUM. Peritoneal Carcinomatosis,Peritoneal Surface Malignancy,Carcinomatosis, Peritoneal,Malignancy, Peritoneal Surface,Neoplasm, Peritoneal,Peritoneal Carcinomatoses,Peritoneal Neoplasm,Peritoneal Surface Malignancies,Surface Malignancy, Peritoneal
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D001959 Bromates Negative ions or salts derived from bromic acid, HBrO3. Bromate
D001966 Bromine A halogen with the atomic symbol Br, atomic number 35, and atomic weight 79.904. It is a volatile reddish-brown liquid that gives off suffocating vapors, is corrosive to the skin, and may cause severe gastroenteritis if ingested. Bromine-79,Bromine 79
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005503 Food Additives Substances used in the processing or storage of foods or animal feed including ANTIOXIDANTS; FOOD PRESERVATIVES; FOOD COLORING AGENTS; FLAVORING AGENTS; ANTI-INFECTIVE AGENTS; EXCIPIENTS and other similarly used substances. Many of the same substances are used as PHARMACEUTIC AIDS. Additive, Food,Additives, Food,Food Additive

Related Publications

Y Kurokawa, and S Aoki, and Y Matsushima, and N Takamura, and T Imazawa, and Y Hayashi
November 1983, Journal of the National Cancer Institute,
Y Kurokawa, and S Aoki, and Y Matsushima, and N Takamura, and T Imazawa, and Y Hayashi
February 1979, Food and cosmetics toxicology,
Y Kurokawa, and S Aoki, and Y Matsushima, and N Takamura, and T Imazawa, and Y Hayashi
January 1988, Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences,
Y Kurokawa, and S Aoki, and Y Matsushima, and N Takamura, and T Imazawa, and Y Hayashi
September 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Y Kurokawa, and S Aoki, and Y Matsushima, and N Takamura, and T Imazawa, and Y Hayashi
February 1979, Food and cosmetics toxicology,
Y Kurokawa, and S Aoki, and Y Matsushima, and N Takamura, and T Imazawa, and Y Hayashi
December 1985, The science reports of the research institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku,
Y Kurokawa, and S Aoki, and Y Matsushima, and N Takamura, and T Imazawa, and Y Hayashi
January 1982, Eisei Shikenjo hokoku. Bulletin of National Institute of Hygienic Sciences,
Y Kurokawa, and S Aoki, and Y Matsushima, and N Takamura, and T Imazawa, and Y Hayashi
January 1998, Toxicologic pathology,
Y Kurokawa, and S Aoki, and Y Matsushima, and N Takamura, and T Imazawa, and Y Hayashi
August 1994, Cancer letters,
Y Kurokawa, and S Aoki, and Y Matsushima, and N Takamura, and T Imazawa, and Y Hayashi
January 1990, Neoplasma,
Copied contents to your clipboard!